INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
LH

Lee Chan Henry

SVP, General CounselCIK 0001980648

EDGAR filingsOpen in network
Disclosed transactions60
Buys / sells0 / 13
Max Insider Score44
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$418K
1,115 sh
Sep 30, 2026Oct 2, 2026
traded Sep 30, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    BeOne Medicines Ltd.SVP, General Counsel · Nov 14, 2025
0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M
—
10.6K sh
Aug 11, 2026
Aug 13, 2026
traded Aug 11, 2026
+2d
SEC FORM 4

Evidence

21
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$960K
2,666 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$158K
812 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

7
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$226K
1,058 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$127K
796 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
10.3K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
13.8K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC FORM 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$157K
590 sh
Jun 16, 2026Jun 18, 2026
traded Jun 16, 2026
+2dSEC FORM 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
45.1K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

2
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
87.3K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$110K
428 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC FORM 4

Evidence

41
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$43K
160 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC FORM 4

Evidence

44
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale
SELL$192K
711 sh
Jun 8, 2026Jun 10, 2026
traded Jun 8, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$20K
101 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

23
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$103K
332 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

4
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
May 13, 2026May 15, 2026
traded May 13, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

13
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$103K
332 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

4
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$20K
101 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC FORM 4

Evidence

4
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$21K
110 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

13
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$102K
341 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,430 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Mar 11, 2026Mar 13, 2026
traded Mar 11, 2026
+2dSEC FORM 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
29.9K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

10
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Grant or award
A—
65.4K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
8,606 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
6,526 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

19
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$349K
996 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

10
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$141K
662 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

6
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$79K
496 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
6,448 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

12
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$232K
664 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$98K
502 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC FORM 4

Evidence

10
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$57K
266 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$39K
202 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
2,548 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
3,458 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
2,626 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

16
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$220K
664 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$31K
196 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

7
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$28K
133 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

3
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M$16K
98 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

16
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Open-market sale · 10b5-1 plan
SELL$108K
332 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,729 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,274 sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

0
LH
Lee Chan HenrySVP, General Counsel
ONCBeOne Medicines Ltd.
Option exercise · 10b5-1 plan
M—
1,313 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence